Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue SUPPL. 1, 1997, Pages

  Lalezari, Jacob P ^a   Kuppermann, Baruch D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Antiviral therapy; Cidofovir; CMV retinitis; Cytomegalovirus; Efficacy; HPMPC

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET; GANCICLOVIR; PROBENECID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; NEPHROTOXICITY; NEUTROPENIA; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RETINITIS; TREATMENT OUTCOME;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030941451     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199700001-00006     Document Type: Conference Paper

References (16)

1. Jacobson MA. Current management of cytomegalovirus disease in patients with AIDS. AIDS Res Hum Retroviruses 1994;10:917-23.
2. + counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-82.
3. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213-20.
4. De Clercq E, Sakuma T, Baba M, et al. Antiviral activity of phos-phonylmethoxyalkyl derivatives of purine and pyrimidines. Antiviral Res 1987;8:261-72.
5. Snoeck R, Sakuma T, De Clercq E, Rosenberg I, Holy A. (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Antimicrob Agents Chemother 1988;32:1839-44.
6. Bronson JJ, Ghazzouli I, Hitchcock MJM, Webb RR II, Martin JC. Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl] cystosine [sic]. J Med Chem 1989;32:1457-63.
7. Lalezari JP, Drew WL, Glutzer E, et al. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I-II study of a novel antiviral nucleotide analogue. J Infect Dis 1995;171:788-96.
8. Polis MA, Spooner KM, Baird BF, et al. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob Agents Chemother 1995;39:882-6.
9. Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem Chemother 1996;7:115-27.
10. Lalezari JP, Kemper C, Stagg R, et al. A randomized, controlled study of the safety and efficacy of intravenous cidofovir (CDV, HPMPC) for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS [Abstract]. Abstracts of the XI International Conference on AIDS 1996; 226:Th.B.304.
11. Lalezari JP, Stagg RJ, Kuppermann BD, et al. A randomized, controlled trial of intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997 (in press).
12. Lalezari J, Holland G, Stagg R, et al. A randomized, controlled study of cidofovir (CDV) for relapsing cytomegalovirus retinitis (CMV-R) in patients with AIDS [Abstract]. Program Addendum for the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy 1995;LB-9.
13. Holland GN, Buhles WC, Mastre B, Kaplan HJ, and the UCLA CMV Retinopathy Study Group. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome. Arch Ophthalmol 1989;107:1759-66.
14. Spector SA, Weingeist T, Pollard RB, et al. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis 1993;168:557-63.
15. Palestine AG, Polis MA, De Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991; 115:665-73.
16. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial: 4. Visual outcomes. Ophthalmology 1994;101:1250-61.